{"id":59984,"date":"2024-09-10T16:05:50","date_gmt":"2024-09-10T14:05:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/"},"modified":"2024-09-10T16:05:50","modified_gmt":"2024-09-10T14:05:50","slug":"cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/","title":{"rendered":"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nFunding will Advance Cellino\u2019s Advanced Biomanufacturing Technology for Personalized Regenerative Medicines<\/li>\n<\/ul>\n<p>CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/biomanufacturing?src=hash\" target=\"_blank\" rel=\"noopener\">#biomanufacturing<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cellinobio.com%2F&amp;esheet=54114110&amp;newsitemid=20240910871353&amp;lan=en-US&amp;anchor=Cellino+Biotech%2C+Inc.&amp;index=1&amp;md5=dc28f2591e6337145412d684101afdcb\" rel=\"nofollow noopener\" shape=\"rect\">Cellino Biotech, Inc.<\/a> today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicines. Cellino\u2019s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/5\/Cellino_X3MODULE.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/22\/Cellino_X3MODULE.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/5\/Cellino_X3MODULE.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/21\/Cellino_X3MODULE.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225952\/5\/Logo_Cellino_Purple.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225952\/22\/Logo_Cellino_Purple.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225952\/5\/Logo_Cellino_Purple.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225952\/21\/Logo_Cellino_Purple.jpg\"><\/a><\/p>\n<p>\nWith ARPA-H\u2019s support, Cellino will build a cassette-based biomanufacturing technology capable of scaling the production of personalized regenerative cells (induced pluripotent stem cells) at hospitals nationwide to develop curative medicines for a range of chronic conditions for an increasingly diverse and aging U.S. patient population. Personalized cells and tissues minimize immune-related complications and improve health equity by obviating the need for a donor match. NEBULA intends to accelerate the approval and deployment of regenerative medicines in development today for diseases such as Parkinson\u2019s, heart disease, spinal cord injury, age-related macular degeneration, and diabetes, which affect more than 50 million Americans.<\/p>\n<p>\n\u201cAt Cellino, we are actively building the industry-leading AI-driven biomanufacturing technology that personalizes cells, tissues, and organs for all, revolutionizing the treatment landscape for humanity\u2019s most burdensome diseases,\u201d said Nabiha Saklayen, Ph.D., CEO &amp; Co-Founder of Cellino. \u201cThis support from ARPA-H will enable us to accelerate our innovation pace to bring potentially curative cell therapies to patients across the nation and beyond.\u201d<\/p>\n<p>\n\u201cWe&#8217;re thrilled to announce this recent support from ARPA-H. This funding empowers us to unlock the potential of regenerative medicine by harnessing cutting-edge advancements in physics, cell therapy technologies, and artificial intelligence,\u201d said Matthias Wagner, CTO &amp; Co-Founder of Cellino. \u201cOur approach is poised to significantly advance the scalability of high-precision biomanufacturing and make \u2018Your cells, your cure\u2019 a reality for millions of patients.\u201d<\/p>\n<p>\n\u201cAdvancements in biomanufacturing, artificial intelligence, and supply chain logistics are all critical pieces to provide cutting-edge therapeutics to people across the country,\u201d said Jason Roos, Ph.D., ARPA-H Scalable Solutions Mission Office Director. \u201cEnhancing affordability and broader access to essential medications is as challenging as developing those novel therapies. ARPA-H is committed to ensuring we can scale manufacturing right alongside other regenerative health innovations.\u201d<\/p>\n<p>\nCellino\u2019s proprietary biomanufacturing technology automates traditionally manual, artisanal processes using an AI-guided, laser-based cell management process to reduce variability and increase the consistency of biomanufactured cell and tissue products. Cellino\u2019s proprietary optical bioprocess will drive a meaningful cost reduction for personalized regenerative medicine biomanufacturing using patient-specific closed cassettes. This effort aligns with ARPA-H\u2019s mission to improve health outcomes for everyone.<\/p>\n<p>\n<b>About Cellino<\/b><\/p>\n<p>\nCellino is building an ultra-scalable, autonomous, high-precision biomanufacturing technology for personalized regenerative medicines. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cellinobio.com&amp;esheet=54114110&amp;newsitemid=20240910871353&amp;lan=en-US&amp;anchor=www.cellinobio.com&amp;index=2&amp;md5=852037ac764b53250c10f4db80a798a4\" rel=\"nofollow noopener\" shape=\"rect\">www.cellinobio.com<\/a> and follow Cellino on X at @<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FCellinoBio&amp;esheet=54114110&amp;newsitemid=20240910871353&amp;lan=en-US&amp;anchor=CellinoBio&amp;index=3&amp;md5=7d2f3a13ff379576f3e67781fac6ea1a\" rel=\"nofollow noopener\" shape=\"rect\">CellinoBio<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media<\/b><br \/>Kimberly Ha<br \/>\n<br \/>KKH Advisors<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;k&#x69;&#109;b&#x65;&#114;&#x6c;&#x79;&#46;&#x68;&#97;&#64;&#x6b;&#107;h&#x61;&#100;&#x76;&#x69;&#115;&#x6f;&#x72;s&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;i&#x6d;b&#x65;&#114;&#x6c;&#121;&#46;&#x68;a&#x40;&#107;&#x6b;&#104;&#x61;&#100;v&#x69;s&#x6f;&#114;&#x73;&#46;&#x63;&#x6f;m<\/a><br \/>917-291-5744<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Funding will Advance Cellino\u2019s Advanced Biomanufacturing Technology for Personalized Regenerative Medicines CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;#biomanufacturing&#8212;Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59984","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Funding will Advance Cellino\u2019s Advanced Biomanufacturing Technology for Personalized Regenerative Medicines CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;#biomanufacturing&#8212;Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-10T14:05:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/22\/Cellino_X3MODULE.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)\",\"datePublished\":\"2024-09-10T14:05:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/\"},\"wordCount\":503,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240910871353\\\/en\\\/2225953\\\/22\\\/Cellino_X3MODULE.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/\",\"name\":\"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240910871353\\\/en\\\/2225953\\\/22\\\/Cellino_X3MODULE.jpg\",\"datePublished\":\"2024-09-10T14:05:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240910871353\\\/en\\\/2225953\\\/22\\\/Cellino_X3MODULE.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240910871353\\\/en\\\/2225953\\\/22\\\/Cellino_X3MODULE.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/","og_locale":"en_US","og_type":"article","og_title":"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Pharma Trend","og_description":"Funding will Advance Cellino\u2019s Advanced Biomanufacturing Technology for Personalized Regenerative Medicines CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;#biomanufacturing&#8212;Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/","og_site_name":"Pharma Trend","article_published_time":"2024-09-10T14:05:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/22\/Cellino_X3MODULE.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)","datePublished":"2024-09-10T14:05:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/"},"wordCount":503,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/22\/Cellino_X3MODULE.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/","url":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/","name":"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/22\/Cellino_X3MODULE.jpg","datePublished":"2024-09-10T14:05:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/22\/Cellino_X3MODULE.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240910871353\/en\/2225953\/22\/Cellino_X3MODULE.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cellino-awarded-25m-in-funding-from-the-advanced-research-projects-agency-for-health-arpa-h\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59984"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59984\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}